Agenus shared a post on LinkedIn:
“Looking ahead to AACR25:
Dr. Myriam Chalabi will present the first results from the NEOASIS trial, evaluating neoadjuvant botensilimab/balstilimab in MSI-H and MSS solid tumors.
Learn more about the presentation.”
More posts featuring Agenus.